Escozine HP (Medolife Corporation)
Welcome to the PulseAid listing for the Escozine HP drug offered from Medolife Corporation. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Medolife Corporation |
NON-PROPRIETARY NAME: | RHOPALURUS PRINCEPS VENOM, Bryonia Alba,Echinacea purpurea |
SUBSTANCE NAME: | ECHINACEA PURPUREA; BRYONIA ALBA ROOT; RHOPALURUS PRINCEPS VENOM |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | LIQUID |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2016-09-30 |
END MARKETING DATE: | 0000-00-00 |
Escozine HP HUMAN OTC DRUG Details:
Item Description | Escozine HP from Medolife Corporation |
LABELER NAME: | Medolife Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10; 30; 3([hp_X]/mL; [hp_C]/mL; [hp_X]/mL) |
START MARKETING DATE: | 2016-09-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 70891-201_3b429454-a71b-68ba-e054-00144ff8d46c |
PRODUCT NDC: | 70891-201 |
APPLICATION NUMBER: | |
Other ECHINACEA PURPUREA; BRYONIA ALBA ROOT; RHOPALURUS PRINCEPS VENOM Pharmaceutical Manufacturers / Labelers: